Biotechnology

CDC clears Novavax Covid-19 vaccine for adults, says shots will be available in the coming weeks

CDC clears Novavax Covid-19 vaccine for adults, says shots will be available in the coming weeks

In this photo illustration a silhouette of a man holding a medical syringe and a vial seen displayed in front of the Novavax logo on a screen. Cezary Kowalski | Lightrocket | Getty Images The Centers for Disease Control and Prevention on Tuesday signed off on Novavax‘s two-dose Covid-19 vaccine as a primary series for …

CDC clears Novavax Covid-19 vaccine for adults, says shots will be available in the coming weeks Read More »

Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot

FDA authorizes Novavax Covid vaccine for adults as the first new shots in U.S. in more than a year

In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration has authorized Novavax‘s two-dose vaccine for adults ages 18 and over, the fourth Covid shot to get emergency approval in the U.S. …

FDA authorizes Novavax Covid vaccine for adults as the first new shots in U.S. in more than a year Read More »

Nasdaq books longest win streak since November as U.S. stocks end mixed after stronger-than-expected jobs report

Nasdaq books longest win streak since November as U.S. stocks end mixed after stronger-than-expected jobs report

U.S. stocks closed mixed Friday, with the technology-heavy Nasdaq Composite ending higher as the Dow Jones Industrial Average and S&P 500 index slipped, after a stronger-than-expected June jobs report. All three major benchmarks booked weekly gains, with the Nasdaq leading the way up. How did stocks trade? Dow Jones Industrial Average DJIA fell 46.40 points, …

Nasdaq books longest win streak since November as U.S. stocks end mixed after stronger-than-expected jobs report Read More »

The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter

The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter

The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week that included putting billions of dollars toward more COVID-19 vaccines and treatments and setting up new rules for how to update the shots.  Here’s what happened this week:  The Food and Drug …

The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter Read More »

Covid vaccines for kids under 5 move closer to FDA authorization after committee backs shots

Covid vaccines for kids under 5 move closer to FDA authorization after committee backs shots

A kindergarten student gives the thumbs up to her teacher before starting the first day of kindergarten at Laguna Niguel Elementary School in Laguna Niguel, CA on Tuesday, August 17, 2021. Paul Bersebach | MediaNews Group | Getty Images Moderna and Pfizer’s Covid-19 vaccines for infants through preschoolers have moved a step closer to authorization …

Covid vaccines for kids under 5 move closer to FDA authorization after committee backs shots Read More »

FDA committee recommends Moderna two-dose Covid vaccine for kids ages 6 to 17

FDA committee recommends Moderna two-dose Covid vaccine for kids ages 6 to 17

A young man receives his Covid-19 vaccination at a vaccination clinic. People receive the Moderna vaccine in Milford, Pennsylvania. Preston Ehrler | LightRocket | Getty Images Moderna’s two-dose Covid-19 vaccine for kids ages 6 through 17 received the endorsement from the Food and Drug Administration’s committee of independent immunization experts on Tuesday, a key step …

FDA committee recommends Moderna two-dose Covid vaccine for kids ages 6 to 17 Read More »

FDA decision on Novavax's Covid shots could be delayed to review changes in manufacturing

FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images The Food and Drug Administration needs to review changes to Novavax‘s manufacturing process before it can authorize the biotech …

FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing Read More »

Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot

Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot

Novavax’s two-dose dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday. The FDA’s committee of independent vaccine experts voted 21 to 0 with one abstention to recommend authorization of the shot for use in the U.S. after an all-day public …

Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot Read More »